1. Mauna Kea Technologies

    0 Comments Leave a Comment

    1-9 of 9
    1. Mentioned In 9 Articles

    2. Device and method for measuring the contrast of the fringes in a michelson interferometer and system for examination of the eye comprising such a device

      Device and method for measuring the contrast of the fringes in a michelson interferometer and system for examination of the eye comprising such a device
      The invention relates to a device, for measuring the contrast of fringes in a Michelson interferometer at full field, comprising a Wollaston prism for diverting two perpendicular incident polarizations into two different emergent directions, said diverting means being arranged within the interferometer as substitute for a single polarizer. The device is of application to a Michelson interferometer used in an OCT tomographical system and comprising means for obtaining interferometric contrast ...
      Read Full Article
    3. First Ever Report of Cellvizio(r) Use in Cystoscopy: New Data On World's Smallest Microscope Presented At American Urology Association (AUA) Annual Meeting

      ...n and the European CE-Mark for use in the gastrointestinal and pulmonary tracts. About Mauna Kea Technologies Mauna Kea Technologies, a French company with a multi-disciplinary scientific approach, has developed Cellvizi...
      Read Full Article
    4. 1-9 of 9
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. About Mauna Kea Technologies

    Mauna Kea Technologies

    Mauna Kea Technologies.  Our founder and CEO's vision was that the power of astronomical technologies could serve physicians, researchers and patients by enabling new medical imaging modalities. This vision was carried out by an extraordinary team of dedicated people from a great variety of disciplines. Over the years, this vision has been reinforced and renewed, opening new horizons as our technologies became available to a greater number of physicians, researchers and therefore to patients. Our first and major innovation is the Cellvizio platform, enabling dynamic in vivo microscopic imaging, almost anywhere in the living body. Cellvizio is now serving the community of gastroenterologists and pulmonologists, as well as a large community of researchers in various fields including neuroscience, cancerology or stem cells. We expect to deliver many more innovative devices in the years to come, complementing our Cellvizio platform or opening new areas of development.